JOHNSON & JOHNSON PROFILE

Johnson & Johnson logo

Johnson & Johnson (JNJ) is a large cap multinational corporation trading on NYSE, part of the health care sector. The company is divided into three major divisions: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson (JNJ) manages 250 operating companies and franchises in 60 countries and is the second largest manufacturer of health care products. This company owns the Tylenol, Band-Aid and Neutrogena brands. Employing 115,500 people, the largest division is pharmaceuticals which brought in $22.5 billion in revenue 2009. The company as a whole reported $3.4 billion net earnings in the third quarter 2010.

Pharmaceuticals that JNJ produces include: Remicade, used in treating Crohn’s disease, psoriatic and rheumatoid arthritis; Topamax which is effective against epilepsy and migraines. The FDA has granted J&J exclusivity for this drug into March of 2009 (pediatric exclusivity). Two other drugs, among many that J&J manufactures, are Procrit (used in treating the loss of red blood cells) and Risperdal (antipsychotic).

Recent news is that Johnson & Johnson sold its St. Joseph’s aspirin brand. In addition, J&J is in the process of acquiring all of the issued and outstanding ordinary shares of Crucell N.V., a Dutch biotech company whose forte is the discovery, manufacturing, and commercialization of vaccines. The reported offer is a stock price per share of €24.75.

Johnson & Johnson’s corporate headquarters is still located in New Brunswick, NJ where it was founded in 1886 by Robert Wood Johnson. One of their early products was the first-ever sterile surgical dressings to be sold commercially. In 1908 the company had 2500 employees. By 1926 they had introduced Johnson’s® Baby Powder and sterile sutures; and international expansion had begun into Canada and England.

Johnson and Johnson became a publicly traded company in 1944 and after that formed and acquired several companies. JNJ stock is considered stable thorugh these aquisitions. Among these was McNeil Laboratories, Inc., which manufactures Tylenol® and Ortho Pharmaceuticals which launched Ortho-Novum in 1963, its first birth control pill. Further acquisitions and internal development over its history has introduced Haldol® (for treating schizophrenia) and the Proximate® Linear Stapler, enabling surgeons to close surgical incisions without sutures. Growth and international expansion has continued through today.


Company Profiles In Healthcare and Pharmaceuticals Sector.

Nuvasive Profile
Bio Rad Labs Profile
Bruker Profile
Myriad Genetics Profile
Health Mgmt Assoc Profile
Vertex Pharmaceuticals Profile
Cephalon Profile
Kinetic Concepts Profile
Salix Pharmaceuticals Profile
Stryker Profile